Lisdexamfetamine Dimesylate Capsules

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Lisdexamfetamine Dimesylate Capsules. Procurement details follow. Lisdexamfetamine Dimesylate: 10 MG, 20 MG, 30 MG, 40 MG, 50 MG, 60 MG, and 70 MG Capsules in 90 Count Bottles and 10 MG, 20 MG, 30 MG, 40 MG, 50 MG, 60 MG, and 70 MG Capsules in 100 Count Bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Indian Health Service, and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Courtney Hunter at (445) 737-3585 or Courtney.Hunter@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is March of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.